We're aiming to increase and extend the use of data in the development and evaluation of our guidance. Data sources could include:
- electronic health record data
- 'real world' data
- relevant data collected outside of the context of traditional trials.
Statement of intent
We've set out our ambitions so that stakeholders and interested individuals can see what we're proposing to do in the future.
We published a draft version earlier this year so that people and organisations could share their perspectives. You can now read the finalised statement of intent.
We're developing further documentation around our methods and processes and setting out our plans for implementation. We'll reflect on the feedback we received during the consultation on these topics.
Email us if you'd like to be contacted about any events and developments in this area.
In June 2019 we published a draft version of the statement of intent. This outlined:
- the evidence we currently use
- the broader types of evidence available
- when and why we'd consider using a broader type of evidence
- practical considerations.
Consultation ran for 3 months. We received comments from more than 130 organisations and individuals.
After reviewing the feedback we've made the following changes to the statement:
- clarification on how these ambitions link to our health technology evaluation methods review
- acknowledgement of additional data sources, including potential emerging forms and sources
- acknowledgement that we may consider international sources of data
- reference to external initiatives
- additional detail about our proposals to ensure transparency
- details about the risks associated with this work, and how we propose to mitigate them.
Find out more
More information about our plans for a data and analytics methods and standards programme is set out in a paper approved by our board in March 2020.